Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06730230 · ClinicalTrials.gov registry record · NA

Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients

A NA study of Hypertension, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06730230 is a NA study of Hypertension that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 300 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06730230, a NA study of Hypertension, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx patients. This study is a step-wedge randomized controlled trial that aims to assess the effectiveness and implementation of RPM-enabled community health workers (CHWs) compared to standard of care RPM hypertension management on blood pressure reduction and evaluate the implementation of the RPM-enabled CHWs for hypertension (HTN) management. The study aims to examine adoption, acceptability, fidelity, cost, sustainability, and equity as outcomes of implementation effectiveness.

Conditions Studied

Interventions

  • BEHAVIORAL Remote Patient Monitoring (RPM)-enabled Community Health Worker (CHW) Support

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-02-10
Est. Completion 2027-05-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06730230

The ClinicalTrials.gov registry entry for NCT06730230 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Remote Patient Monitoring (RPM)-enabled Community Health Worker (CHW) Support is the first listed.

NCT06730230 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06730230 about?

NCT06730230 is a clinical study titled "Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients". This study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx patients. This study is a step-wedge randomized controlled trial that aims to assess the effectivenes...

What is the current status of trial NCT06730230?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-02-10. Estimated completion is 2027-05-31.

What conditions does trial NCT06730230 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT06730230?

The interventions under investigation include: Remote Patient Monitoring (RPM)-enabled Community Health Worker (CHW) Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06730230?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06730230 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.